Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?
Wiesener, Solveig; Salamonsen, Anita; Fønnebø, Vinjar.
BMC Complement Altern Med
; 18(1): 11, 2018 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-29321023
Researching complementary and alternative treatments--the gatekeepers are not at home.
Supportive but "worried": perceptions of naturopaths, homeopaths and Chinese medicine practitioners through a regulatory transition in Ontario, Canada.
A trajetória da introdução e regulamentação da acupuntura no Brasil: memórias de desafios e lutas
'Hodge-podge' regulation of alternative medicine in Canada.
Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study.
Complementary and alternative medicine for the allergist-immunologist: where do I start?
Alternative medicine on trial. Clinical trials home in on complementary therapies and complex natural products.
The Need to Develop a Regulatory Body for the Practice of Al-Hijama.
The use of medicinal plants as a therapeutical resource: from the influences of the professional formation to the ethical and legal implications of its applicability as an extension of nursing care practice.
Complementary and alternative medicine: assessing the evidence for immunological benefits.